Literature DB >> 26418076

Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.

Hiroki Nishikawa1, Hirayuki Enomoto1, Yoshinori Iwata1, Kunihiro Hasegawa1, Chikage Nakano1, Ryo Takata1, Takashi Nishimura1, Kazunori Yoh1, Nobuhiro Aizawa1, Yoshiyuki Sakai1, Naoto Ikeda1, Tomoyuki Takashima1, Akio Ishii1, Hiroko Iijima1, Shuhei Nishiguchi1.   

Abstract

AIM: We aimed to examine the relationship between serum Wisteria floribunda agglutinin positive Mac-2-binding protein (WFA(+) -M2BP) levels and serum interferon-γ-inducible protein-10 (IP-10) levels and liver histological findings for patients with primary biliary cirrhosis (PBC) compared with other laboratory fibrotic or inflammatory parameters.
METHODS: A total of 57 PBC patients were analyzed. Receiver-operator curve (ROC) analysis was performed for calculating the area under the ROC (AUROC) for WFA(+) -M2BP, IP-10 and four serum fibrosis markers for the presence of liver cirrhosis (F4) or advanced fibrosis (F3 or F4). Similarly, ROC analysis of WFA(+) -M2BP, IP-10, aspartate aminotransferase and alanine aminotransferase for the presence of severe inflammation activity (A3) was performed.
RESULTS: There were eight men and 49 women (median age, 59 years). As for histological findings, F4 was observed in five patients, F3 in 11, F2 in 17, F1 in 24 and F0 in zero, whereas A3 was observed in seven patients, A2 in 27, A1 in 19 and A0 in four. The WFA(+) -M2BP levels ranged from 0.5 cut-off index (COI) to 13.6 COI (median, 1.8), while serum IP-10 levels ranged 121.9-1835.9 pg/mL (median, 571.5). For predicting liver cirrhosis, WFA(+) -M2BP yielded the highest AUROC (0.97, P < 0.01). For predicting severe liver inflammation activity (A3), WFA(+) -M2BP and serum IP-10 yielded the highest AUROC with a level of 0.87. WFA(+) -M2BP levels significantly correlated with serum IP-10 levels (rs  = 0.55, P < 0.0001).
CONCLUSION: Serum WFA(+) -M2BP and serum IP-10 can be useful markers for predicting histological findings in PBC patients.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  Wisteria floribunda agglutinin positive Mac-2-binding protein; inflammation activity; interferon-γ-inducible protein-10; liver fibrosis; primary biliary cirrhosis

Year:  2015        PMID: 26418076     DOI: 10.1111/hepr.12595

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  17 in total

Review 1.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

2.  Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.

Authors:  Thuy Thi Thu Pham; Dat Tan Ho; Toan Nguyen
Journal:  World J Hepatol       Date:  2020-05-27

3.  M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection.

Authors:  Bin Wei; Shu Feng; Enqiang Chen; Dongdong Li; Tingting Wang; Yu Gou; Tingting Yang; Dongmei Zhang; Chuanmin Tao; Hong Tang
Journal:  J Clin Lab Anal       Date:  2017-05-24       Impact factor: 2.352

4.  Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.

Authors:  Masataka Kanno; Kazunori Kawaguchi; Masao Honda; Rika Horii; Hajime Takatori; Tetsuro Shimakami; Kazuya Kitamura; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2019-02-01       Impact factor: 7.527

5.  Cytokines predict virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy.

Authors:  Wen-Kang Fu; Jie Cao; Ning-Ning Mi; Chong-Fei Huang; Long Gao; Jin-Duo Zhang; Ping Yue; Bing Bai; Yan-Yan Lin; Wen-Bo Meng
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

6.  B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Kyohei Kishino; Yoshihiro Shimono; Kunihiro Hasegawa; Chikage Nakano; Ryo Takata; Takashi Nishimura; Kazunori Yoh; Akio Ishii; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.

Authors:  Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Yoshinori Iwata; Akio Ishii; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis.

Authors:  Yoshihiro Kamada; Masafumi Ono; Hideyuki Hyogo; Hideki Fujii; Yoshio Sumida; Makoto Yamada; Kojiroh Mori; Saiyu Tanaka; Tomohiro Maekawa; Yusuke Ebisutani; Akiko Yamamoto; Shinji Takamatsu; Masashi Yoneda; Norifumi Kawada; Kazuaki Chayama; Toshiji Saibara; Tetsuo Takehara; Eiji Miyoshi
Journal:  Hepatol Commun       Date:  2017-08-16

9.  Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.

Authors:  Kunihiro Hasegawa; Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

10.  Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.

Authors:  Ming-Yu Zhu; Pei-Zhan Chen; Jing Li; De-Min Yu; Dao Huang; Xue-Juan Zhu; Yue Han; Jie Chen; Wei Huang; Yong-Yan Chen; Qi-Ming Gong; Jie-Hong Jiang; Dong-Hua Zhang; Yan Zhang; Ji-Ming Zhang; Xin-Xin Zhang
Journal:  J Med Virol       Date:  2018-01-12       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.